Table 2. ROI connection details.

	RS1				RS2
Conn	Escit	Plac	T	P	Escit	Plac	T	P
PCC-RIPC	.98	1.30	−3.7	.005	1.06	1.32	−4.0	.003
PCC-RPHC	.27	.73	−4.7	.001	.32	.82	−7.6	<.001
RIPC-RPHC	.21	.60	−3.4	.008	.20	.68	−8.5	<.001
LIPC-RPHC	.17	.60	−4.2	.002	.24	.63	−4.6	.001
RPHC-ACC	.14	.40	−2.5	.037	.18	.48	−6.0	<.001
RPHC-RMFG	.12	.43	−3.6	.006	.25	.43	−2.2	0.058

For each significant pairwise connection (Conn) the average connectivity values after Escitalopram (Escit) and Placebo (Plac) administration are shown, together with the paired-sample T-test statistics (degrees of freedom = 9), for both resting states RS1 and RS2. Abbreviations, see main text.